Psychother Psychosom Med Psychol 2018; 68(08): e8
DOI: 10.1055/s-0038-1667891
SYMPOSIEN
Leben nach einer Blutkrebserkrankung: Symptombelastung und Möglichkeiten der Intervention
Georg Thieme Verlag KG Stuttgart · New York

Adaptation of a web-based cognitive-behavioral therapy on fatigue for survivors of Hodgkin's lymphoma

P Esser
1   Universitätsmedizin Leipzig, Abteilung für Medizinische Psychologie und Medizinische Soziologie, Leipzig, Deutschland
,
P Borchmann
2   Köln, Deutschland
,
K Kuba
1   Universitätsmedizin Leipzig, Abteilung für Medizinische Psychologie und Medizinische Soziologie, Leipzig, Deutschland
,
H Müller
2   Köln, Deutschland
,
H Görgen
2   Köln, Deutschland
,
S Kreissl
2   Köln, Deutschland
,
R Scheuvens
2   Köln, Deutschland
,
A Mehnert
1   Universitätsmedizin Leipzig, Abteilung für Medizinische Psychologie und Medizinische Soziologie, Leipzig, Deutschland
› Author Affiliations
Further Information

Publication History

Publication Date:
06 August 2018 (online)

Also available at
 

Background:

Cancer-related fatigue (CRF) is one of the most common patient-reported impairments in survivors of Hodgkin's lymphoma and is associated with adverse effects on psychological well-being and everyday life including family, work and social participation. Therefore, a Dutch research group has developed a web-based intervention for severely fatigued cancer survivors. However, this intervention is still not available in German and has not been adapted for survivors of Hodgkin's lymphoma.

Methods:

We here present a bi-centric (Cologne and Leipzig) pilot-study of this web-based intervention on CRF. In detail, we will conduct a non-randomized and non-controlled before-and-after study in a minimum of 20 survivors of Hodgkin's lymphoma. Levels of fatigue will be measured before the intervention, post-intervention and at 3-months follow-up.

Results:

We will provide results on our study aims, which are (i) translation and adaptation of the intervention manual, (ii) information regarding the feasibility of the intervention and (iii) preliminary results on the efficacy of the program in reducing CRF.

Discussion & Conclusions:

The results of this pilot-study will provide essential information to conduct a future randomized clinical trial to investigate the efficacy of this intervention in reducing CRF in survivors with Hodgkin's lymphoma.